| Jan 14, 2022 |
Jan 18, 2022 |
Tharimmune, Inc.
|
Director |
Buy |
95.0
|
+25,000
|
25.32%
|
✗
|
$100K |
| Sep 27, 2019 |
Sep 27, 2019 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
100.0
|
+2,234,700
|
27.86%
|
✗
|
$2M |
| Apr 3, 2019 |
Apr 5, 2019 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
100.0
|
+1,165,048
|
16.99%
|
✗
|
$1.8M |
| Aug 13, 2018 |
Aug 15, 2018 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
100.0
|
+3,137,255
|
84.37%
|
✗
|
$4M |
| Mar 29, 2018 |
Apr 2, 2018 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
90.0
|
+167,504
|
4.72%
|
✗
|
$500K |
| Dec 19, 2017 |
Jan 8, 2018 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
92.5
|
+213,106
|
6.38%
|
✗
|
$999.5K |
| Aug 24, 2017 |
Aug 28, 2017 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
61.3
|
+11,000
|
0.33%
|
✗
|
$29.5K |
| Aug 8, 2017 |
Aug 10, 2017 |
Citius Pharmaceuticals, Inc.
|
Chair |
Buy |
100.0
|
+421,400
|
31.02%
|
✗
|
$1.7M |
| Mar 30, 2016 |
Apr 12, 2016 |
Citius Pharmaceuticals, Inc.
|
Director |
Buy |
100.0
|
+20,116,746
|
368.63%
|
✗
|
$3M |